SPOTLIGHT -
Tourette’s or Mass Sociogenic Illness? You Decide
According to German researchers, YouTube and other online platforms could induce a “mass social media-induced illness.”
The AMA’s 7 Recommendations for Reducing the Opioid Crisis
The American Medical Association is urging policymakers to act now to prevent further opioid overdose deaths.
A Vaccine to Treat Opioid Disorders: First Participant Enrolled in Trial
A vaccine that prevents oxycodone from entering the brain? This might be the safe, long-lasting, cost-effective solution for opioid use disorders.
Afghanistan Veterans Struggling With Mental Health
A recent survey found 70% of Afghanistan veterans have struggled with their mental health since serving.
FDA Workshop Plans to Discuss Potential Mandatory Opioid Prescriber Education
The FDA is holding a workshop to discuss mandatory opioid prescriber education through the Opioid Analgesic Risk Evaluation and Mitigation Strategy.
Nasal Spray for Treatment of Migraine Approved by FDA
The first and only treatment to use proprietary precision olfactory delivery technology to deliver DHE to the upper nasal cavity just received FDA approval.
APA and Other Leading Physician Groups Oppose Texas Legislation That Interferes With Patient Reproductive Care
6 frontline physician groups expressed their concern about the Texas state law that bans abortions after 6 weeks of pregnancy.
First and Only Twice-Yearly Treatment for Schizophrenia Receives FDA Approval
The one-of-its-kind 6-month paliperidone palmitate treatment for schizophrenia has received FDA approval.
Suicide: The Lesser-Known Hazard for Construction Workers
According to the CDC, construction workers commit suicide 4 times more than the general population. What can be done to stem this hazard?
Addressing Afghanistan: The American Psychiatric Association’s Statement
Mental health care for US service members, refugees, and Afghans will be crucial.
In the Wake of 9/11: Mental Health Statistics of First Responders
What toll does trauma take on police officers, firefighters, and EMT workers?
Study Shows Pandemic Resulted in Increases in Intimate Partner Aggression
First of its kind study found aggression in US couples saw a 6- to 8-fold increase during the pandemic.
Meeting the Needs of Correctional Health Care Clinicians: NCCHC Holds Educational Conference for First Time in 2 Years
The National Correctional Health Care Conference is back and ready to deliver the latest on correctional and public health.
Developing a Novel Psychedelic: Salvinorin A
A kappa-opioid receptor with psychedelic effects, this potential agent for treatment-resistant depression and other disorders will be paired with a digital therapeutic for maximum efficacy.
First and Only Medicine Indicated to Treat Idiopathic Hypersomnia
This hypersomnia treatment just received an extended approval for cataplexy and excessive daytime sleepiness.
Do Amyloid Plaques Cause Alzheimer Disease?
A new study finds amyloid plaques accelerate the breakup of neurotransmitters, worsening neurodegenerative diseases like Alzheimer disease.
When Music Makes a Difference: Documentary Wins Award
The documentary Orchestrating Change has won the 2021 Austen Riggs Erikson Prize for Excellence in Mental Health Media.
Moving Forward: Alzheimer Treatment Granted Breakthrough Therapy Designation
More potential good news for treating Alzheimer disease, as an 18-month open-label extension for lecanemab allows for its breakthrough status.
Positive End-Of-Phase 2 Meeting for Extended-Release Risperidone Capsule
An extended release, ultra-long acting antipsychotic takes another step forward in the approval process.
Fighting the Opioid Epidemic: The APA’s Call to Action
After the largest increase in overdose deaths in 50 years, the American Psychiatric Association sends out the call for improved substance use care.
New Treatment for Acute Suicidal Ideation and Behavior
If approved, SLS-002 would be only the second approved product for ASIB.
Do Blood Clotting and Immune System Contribute to Psychosis?
New research may help better understand psychosis etiology as well as provide potential biomarkers for psychosis.
First Participant Joins Opioid Use Disorder Treatment Study
Novel digital therapy modia will be evaluated in combination with sublingual buprenorphine/naloxone background therapy to see whether it is superior in reducing opioid use.
Rhode Island: The First State to Allow Harm Reduction Centers for Safe Drug Consumption
To combat drug overdoses, the Rhode Island governor signed a bill allowing people to consume pre-obtained drugs under safe, professional supervision of trained staff.
Narrower Label for Alzheimer Disease Treatment, Aducanumab
Following criticism for its wide-labeled June approval, the FDA has decided to narrow the patient recommendation for aducanumab.
Another New Alzheimer Drug on the Horizon
Donanemab for the treatment of Alzheimer disease has received Breakthrough Therapy designation from the FDA.
Scotland Introduces Bill in Favor of Assisted Dying
For the first time since 2015, Scottish Parliament is considering legislation on medical aid in dying.
Challenging Diagnoses, New Treatments, and Clinical Conundrums Discussed at Annual Meeting
The 2021 American Psychiatric Association Virtual Annual Meeting brought together leaders in psychiatry to discuss hot topics including diversity, COVID-19, mood disorders, and more.
Vaccines Do Not Affect Male Fertility
According to a recent study, COVID-19 vaccines did not impact sperm parameters.
Patent Brings Psychiatry One Step Closer to Precision Medicine
Adial’s AD04 for the treatment of alcohol use disorder received a Notice of Allowance from the US Patent and Trademark Office.